Precision Optics Inc Revenue Growth Rates (POCI), Current and Historic Growth - CSIMarket
CSIMarket
 


Precision Optics Corporation Inc   (NASDAQ: POCI)
 

POCI's Revenue Growth by Quarter and Year

Precision Optics Inc 's Revenue results by quarter and year




POCI Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March 8.71
2nd Quarter December 7.37
1st Quarter September 6.68
FY 22.76

POCIs Annual Revenue
Precision Optics Inc 's Revenue in the fiscal year 2025 $ 19.09 millions
Precision Optics Inc 's Revenue in the fiscal year 2024 $ 19.10 millions
Precision Optics Inc 's Revenue in the fiscal year 2023 $ 21.04 millions
Precision Optics Inc 's Revenue in the fiscal year 2022 $ 15.68 millions
Precision Optics Inc 's Revenue in the fiscal year 2021 $ 10.67 millions




POCI Revenue third quarter 2026 Y/Y Growth Comment
Precision Optics Corporation Inc achieved in the third quarter 2026, above Company average Revenue surge of 107.84% year on year, to $ 8.71 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 124 other companies have achieved higher Revenue growth. While Precision Optics Corporation Inc ' s Revenue doubling of 107.84% ranks overall at the positon no. 2491 in the third quarter 2026.




POCI Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter June - 30.93 % -5.98 % 4.8 %
3rd Quarter March 107.84 % -20.04 % 3.76 % 8.6 %
2nd Quarter December 62.69 % -6.02 % -18.17 % 51.03 %
1st Quarter September 59.05 % -2.78 % -15.13 % 117.52 %
FY   - 0 % -9.26 % -

Financial Statements
Precision Optics Inc 's third quarter 2026 Revenue $ 8.71 millions POCI's Income Statement
Precision Optics Inc 's third quarter 2025 Revenue $ 4.19 millions Quarterly POCI's Income Statement


POCI Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter June - 47.49 % -9.92 % -0.59 %
3rd Quarter March 18.16 % -7.51 % 8.71 % -14.26 %
2nd Quarter December 10.33 % 7.86 % 11.57 % 15.72 %
1st Quarter September 8.09 % -11.02 % -13.94 % 6.26 %
FY (Year on Year)   - 0 % -9.26 % -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #125
Healthcare Sector #366
Overall #2491

Revenue Y/Y Growth Statistics
High Average Low
390.03 % 40.31 % -19.46 %
(Dec 31 2015)   (Jun 30 2017)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #125
Healthcare Sector #366
Overall #2491
Revenue Y/Y Growth Statistics
High Average Low
390.03 % 40.31 % -19.46 %
(Dec 31 2015)   (Jun 30 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Precision Optics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
98.6 % 7.45 % -29.19 %
(Jun 30 2018)  


POCI's III. Quarter Q/Q Revenue Comment
Precision Optics Corporation Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 18.16%, to $ 8.71 millions, from $7.37 millions in the second quarter.
POCI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Precision Optics Inc 's Revenue growth quarter on quarter, overall rank is 435.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #81
Overall #435
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #18
Healthcare Sector #81
Overall #435
Revenue Q/Q Growth Statistics
High Average Low
98.6 % 7.45 % -29.19 %
(Jun 30 2018)  


POCI's III. Quarter Q/Q Revenue Comment
Precision Optics Corporation Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 18.16%, to $ 8.71 millions, from $7.37 millions in the second quarter.
POCI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 17 other companies have achieved higher Revenue quarter on quarter growth. While Precision Optics Inc 's Revenue growth quarter on quarter, overall rank is 435.


Precision Optics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 28.94 $ 24.42 $ 21.58 $ 19.09 $ 17.63
Y / Y Revenue Growth (TTM) 64.18 % 30.69 % 13.67 % -0.07 % -9.2 %
Year on Year Revenue Growth Overall Ranking # 2603 # 749 # 2489 # 2667 # 2672
Seqeuential Revenue Change (TTM) 18.52 % 13.17 % 13.01 % 8.31 % -5.66 %
Seq. Revenue Growth (TTM) Overall Ranking # 2491 # 715 # 2118 # 2201 # 2018


Cumulative Revenue growth Comment
Precision Optics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 64.18% year on year, to $ 29 millions if the fiscal year would have ended in Mar 31 2026.
Precision Optics Inc 's trailing twelve months Revenue growth was higher than company's average 40.31% and higher than 30.69% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 18.52 % from $24.42 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at40.31%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 18.52 % increase from $24.42 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 375 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 749 to 2603.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 376
Overall # 2603

Revenue TTM Y/Y Growth Statistics
High Average Low
390.03 %
40.31 %
-19.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 366
S&P 500 # 2491
Cumulative Revenue growth Comment
Precision Optics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 64.18% year on year, to $ 29 millions if the fiscal year would have ended in Mar 31 2026.
Precision Optics Inc 's trailing twelve months Revenue growth was higher than company's average 40.31% and higher than 30.69% growth in Dec 31 2025.
But from twelve months ended Dec 31 2025 rise was beneth at 18.52 % from $24.42 millions achieved in the period from Dec 31 2025 to Mar 31 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at40.31%.
The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 18.52 % increase from $24.42 millions in the period from Dec 31 2025 to Mar 31 2025.

In the Healthcare sector 375 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 749 to 2603.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 376
Overall # 2603

Revenue TTM Y/Y Growth Statistics
High Average Low
390.03 %
40.31 %
-19.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 366
S&P 500 # 2491




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
POCI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Renovorx Inc 185.79%$ 185.787 millions
Cardio Diagnostics Holdings Inc 185.11%$ 185.106 millions
Ars Pharmaceuticals Inc 184.47%$ 184.473 millions
Tonix Pharmaceuticals Holding Corp 183.16%$ 183.162 millions
Dyadic International Inc 182.28%$ 182.275 millions
Nuo Therapeutics Inc 168.82%$ 168.820 millions
Immunitybio inc 167.64%$ 167.639 millions
Allogene Therapeutics Inc 166.67%$ 166.667 millions
Ironwood Pharmaceuticals inc 158.87%$ 158.868 millions
Urogen Pharma Ltd 155.07%$ 155.069 millions
Agios Pharmaceuticals Inc 137.75%$ 137.749 millions
Uniqure N v 127.31%$ 127.313 millions
Madrigal Pharmaceuticals Inc 126.84%$ 126.839 millions
Marker Therapeutics inc 115.32%$ 115.320 millions
Mobia Medical Inc 113.28%$ 113.284 millions
Precision Optics Corporation Inc 108.04%$ 108.043 millions
Inspiremd Inc 107.97%$ 107.972 millions
Tarsus Pharmaceuticals Inc 106.87%$ 106.873 millions
Phathom Pharmaceuticals Inc 104.43%$ 104.429 millions
Profound Medical Corp 103.62%$ 103.625 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________102.69%$ 102.686 millions
Vivos Therapeutics Inc 101.63%$ 101.634 millions
Protagonist Therapeutics inc 99.03%$ 99.033 millions
Alnylam Pharmaceuticals Inc 96.43%$ 96.432 millions
Abcellera Biologics Inc 96.34%$ 96.340 millions
Viridian Therapeutics Inc 95.83%$ 95.833 millions
Alamar Biosciences Inc 94.46%$ 94.462 millions
Bioage Labs Inc 91.04%$ 91.041 millions
Tenon Medical Inc 89.94%$ 89.945 millions
Vaxart Inc 87.90%$ 87.905 millions


About Precision Optics Inc Revenue Growth Rates (POCI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Precision Optics Corporation Inc (CIK 867840).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001683168-26-003818
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Precision Optics Corporation Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.